[1]杨玉娟,金智生.基于肠道菌群的助脾散精法改善2型糖尿病胰岛素抵抗作用探讨[J].中国中医药信息杂志,2021,28(2):8-11.[doi:10.19879/j.cnki.1005-5304.202004701]
 YANG Yujuan,JIN Zhisheng.Discussion on Effect of Zhupi Sanjing Method for Improving Insulin Resistance in Type 2 Diabetes Based on Intestinal Flora[J].zhongguo zhongyiyao xinxi zazhi,2021,28(2):8-11.[doi:10.19879/j.cnki.1005-5304.202004701]
点击复制

基于肠道菌群的助脾散精法改善2型糖尿病胰岛素抵抗作用探讨

参考文献/References:

[1] 陈诚,陆明,夏娟,等.肠道菌群与2型糖尿病关系的研究进展[J].医学综述,2017,23(15):3072-3076.

[2] 岳仁宋,陈源,王帅,等.试论助脾散精法治疗糖尿病[J].新中医, 2011,43(2):155-156.

[3] CHAMBERS E S, BYRN C S, MORRISON D J, et al. Dietary supplementation with inulin-propionate ester or inulin improves insulin sensitivity in adults with overweight and obesity with distinct effects on the gut microbiota, plasma metabolome and systemic inflammatory responses:a randomised cross-over trial[J]. Gut,2019,68(8):1430-1438.

[4] NADERPOOR N, MOUSA A, GOMEZ-ARANGO L F, et al. Faecal microbiota are related to insulin sensitivity and secretion in overweight or obese adults[J]. J Clin Med,2019,8(4):452.

[5] KREZNAR J H, KELLER M P, TRAEGER L L, et al. Host genotype and gut microbiome modulate insulin secretion and diet-induced metabolic phenotypes[J]. Cell Reports,2017,18(7):1739-1750.

[6] KOH A, DE VADDER F, KOVATCHEVA-DATCHARY P, et al. From dietary fiber to host physiology:Short-chain fatty acids as key bacterial metabolites[J]. Cell,2016,165(6):1332-1345.

[7] EVERARD A, CANI P D. Diabetes, obesity and gut microbiota[J]. Best Pract Res Clin Gastroenterol,2013,27(1):73-83.

[8] CANI P D, AMAR J, IGLESIAS M A, et al. Metabolic endotoxemia initiates obesity and insulin resistance[J]. Diabetes,2007, 56(7):1761-1772.

[9] BOUTAGY N E, MCMILLAN R P, FRISARD M I, et al. Metabolic endotoxemia with obesity:is it real and is it relevant?[J]. Biochimie,2016,124:11-20.

[10] 张国荣,刘海鸿,陶柯衡,等.肠道菌群与糖尿病的研究进展[J].中国微生态学杂志,2018,30(1):121-124.

[11] 迟诚,齐海宇,阴赪宏.肠道微生态与2型糖尿病的关系[J].中国医刊,2019,54(6):585-588.

[12] 李雷,杨云梅,吴月.老年2型糖尿病患者肠道菌群多样性及其炎症因子与胰岛素抵抗的相关性研究[J].中华危重症医学杂志(电子版), 2018,11(5):316-321.

[13] 卢朝秀,吴飞飞.肠道微生物群与2型糖尿病的研究进展[J].中国微生态学杂志,2019,31(7):866-869.

[14] 聂春丽,李靖,郑世静,等.中西医结合治疗2型糖尿病胰岛素抵抗的Meta分析[J].世界中医药,2018,13(3):767-775.

[15] 王德惠,吴贤顺,李晋宏,等.从脾虚“脾不散精”或“散精障碍”探讨糖尿病的中医病机[J].中医杂志,2014,55(22):1906-1908.

[16] 许成群,李中南,周元平.基于“湿滞津停”理论治疗2型糖尿病思路探析[J].辽宁中医杂志,2015,42(10):1885-1887.

[17] 刘鑫,曲超,王姝婷,等.基于数据挖掘的中药治疗2型糖尿病用药规律分析[J].中华中医药学刊,2020,38(5):74-78.

[18] 张爱霞,岳仁宋,杨彩虹.助脾散精法治疗2型糖尿病胃强脾弱证46例疗效观察[J].四川中医,2012,30(10):96-97.

[19] 陈源.助脾散精法治疗2型糖尿病(脾气虚夹湿证)的初步临床研究[D].成都:成都中医药大学,2011.

[20] 韩煦,姚政,李俊燕,等.健脾清化方改善2型糖尿病大鼠肠道胰岛素抵抗[J].中华中医药杂志,2019,34(7):2973-2977.

[21] 韩煦,姚政,李俊燕,等.健脾清化方对2型糖尿病大鼠肠道免疫细胞Th1/Th2/Th17/Treg的影响[J].辽宁中医杂志,2019,46(7):1532-1534, 1570.

[22] EWASCHUK J B, DIELEMAN L A. Probiotics and prebiotics in chronic inflammatory bowel diseases[J]. World Journal of Gastroenterology, 2006,12(37):5941-5950.

[23] 王卓,彭颖,李晓波.四君子汤对两种脾虚模型大鼠肠道菌群紊乱的影响[J].中国中西医结合杂志,2009,29(9):825-829.

[24] 杨旭,岳仁宋,徐萌,等.从“脾主谏议”角度探讨半夏泻心汤对DGP模型大鼠肠道免疫功能的影响[J].时珍国医国药,2019,30(9):2078- 2081.

[25] 柯一帆,马芳笑,钟继红,等.19例不同中医证型溃疡性结肠炎患者肠道菌群的差异性[J].中医杂志,2019,60(22):1935-1941.

[26] 刘名波.香砂六君子汤对脾虚泄泻免疫功能和肠道微生态的影响[D].苏州:苏州大学,2015.

[27] 马祥雪,王凤云,符竣杰,等.基于肠道菌群的中医健脾方剂作用机制的研究现状与思考[J].中国实验方剂学杂志,2017,23(5):210-215.

[28] SHI K, QU L H, LIN X, et al. Deep-fried atractylodis rhizoma protects against spleen deficiency-induced diarrhea through regulating intestinal inflammatory response and gut microbiota[J]. International journal of molecular sciences,2019, 21(1):124.

[29] 沙薇.参苓白术散治疗脾虚泄泻经验总结[J].世界最新医学信息文摘,2018,18(99):180.

[30] 覃俏娜,陈红霞,李双蕾.肠道菌群与2型糖尿病的中西医相关性研究[J].亚太传统医药,2017,13(5):59-62.

[31] 刘小溪,李小娟,石岩,等.益气补脾法配合二甲双胍干预脾虚证2型糖尿病患者肠道菌群的临床研究[J].辽宁中医杂志,2017,44(11):2311-2313.

[32] 郇鹏飞,金智生,高钰莹,等.基于肠道微生态探讨2型糖尿病从脾虚论治机理[J].中国中医药信息杂志,2019,26(5):8-10.

[33] 方朝晖.参术调脾颗粒对糖尿病大鼠TNF-α、IL-6和肠道菌群的影响[C]//中华中医药学会.中华中医药学会糖尿病分会2017年学术年会暨第十八次中医糖尿病大会论文汇编.延边,2017:149.

[34] 王晶.基于“助脾散精”法探讨半夏泻心汤对T2DM患者肠道菌群及细胞免疫的影响[D].成都:成都中医药大学,2019.

相似文献/References:

[1]张爱萍.黄连素对多囊卵巢综合征胰岛素抵抗的影响[J].中国中医药信息杂志,2013,20(12):70.[doi:10.3969/j.issn.1005-5304.2013.12.027]
 [J].zhongguo zhongyiyao xinxi zazhi,2013,20(2):70.[doi:10.3969/j.issn.1005-5304.2013.12.027]
[2]徐江红,吴中秋,佟杰,等.耳针与中药并用治疗2型糖尿病临床疗效及对胰岛素抵抗的影响[J].中国中医药信息杂志,2009,16(2):61.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):61.
[3]卢芙蓉,秦铀,沈霖,等.胡芦巴总皂苷对饮食诱导肥胖大鼠糖脂代谢及胰岛素抵抗的影响[J].中国中医药信息杂志,2010,17(9):34.[doi:10.3969/j.issn.1005-5304.2010.09.015]
 LU Fu-rong,QIN You,SHEN Lin,et al.Effect of Trigonella Foenum-graecum Saponin on Blood Glucose and Lipid Metabolism and Insulin Resistance in Diet-induced Obese Rats[J].zhongguo zhongyiyao xinxi zazhi,2010,17(2):34.[doi:10.3969/j.issn.1005-5304.2010.09.015]
[4]梁凤霞,王华,陈泽斌.“双固一通”针法对糖尿病大鼠血清IL-6的影响[J].中国中医药信息杂志,2007,14(1):28.
 LIANG Feng-xia,WANG Hua,et al.Effect of “Shuangguyitong” Acupuncture Therapy on Serum Interleukin-6 of STZ-induced Diabetic Rats[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):28.
[5]李强,朱德增.2型糖尿病胰岛素抵抗的中医药研究概况[J].中国中医药信息杂志,2007,14(1):92.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):92.
[6]王兵,朱平生.舒肝活血化痰方对非酒精性脂肪性肝炎大鼠血清瘦素、胰岛素抵抗指数的影响[J].中国中医药信息杂志,2007,14(2):39.
 WANG Bing,ZHU Ping-Sheng.Effect of Shugan Huoxue Huatan Decoction on Insulin Resistance in Rats with Non-alcoholic Steatohepatitis[J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):39.
[7]田颖欣.消渴方改善胰岛素抵抗临床观察[J].中国中医药信息杂志,2007,14(2):55.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(2):55.
[8]冉颖卓,高瞾.清热燥湿健脾方药对早期2型糖尿病胰岛素抵抗及TNF-α的影响[J].中国中医药信息杂志,2009,16(9):14.
 RAN Ying-zhuo,GAO Zhao.Effect of Herbs of Cleaning away Heat, Drying Dampness and Invigorating Spleen on Insulin Resistance and TNF-α of Patients with Early Stage of Type 2 Diabetes Mellitus[J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):14.
[9]陈娟,沈海萍,阎纳新.中西医结合治疗2型糖尿病胰岛素抵抗临床观察[J].中国中医药信息杂志,2009,16(12):70.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(2):70.
[10]李爱民.人参健心胶囊对冠心病患者胰岛素抵抗及纤维蛋白溶解活性的影响[J].中国中医药信息杂志,2008,15(2):12.
 LI Ai-min.Effect of Renshen Jianxin Capsule on Insulin Resistance and Coagulation in Coronary Heart Disease[J].zhongguo zhongyiyao xinxi zazhi,2008,15(2):12.

备注/Memo

基金项目:国家自然科学基金地区基金(81660777)

更新日期/Last Update:

2021-01-25